Haixia Fu

ORCID: 0000-0002-4485-5276
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Platelet Disorders and Treatments
  • Hematopoietic Stem Cell Transplantation
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Blood groups and transfusion
  • Systemic Lupus Erythematosus Research
  • Cytomegalovirus and herpesvirus research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Neurosurgical Procedures and Complications
  • SARS-CoV-2 and COVID-19 Research
  • Ginseng Biological Effects and Applications
  • COVID-19 and healthcare impacts
  • COVID-19 Clinical Research Studies
  • Parvovirus B19 Infection Studies
  • Head and Neck Surgical Oncology
  • Intracranial Aneurysms: Treatment and Complications
  • Autoimmune Bullous Skin Diseases
  • Bone and Joint Diseases
  • Chemokine receptors and signaling
  • Retinoids in leukemia and cellular processes
  • Vascular Malformations Diagnosis and Treatment
  • Vascular Procedures and Complications
  • Reconstructive Surgery and Microvascular Techniques
  • Chronic Lymphocytic Leukemia Research
  • Reproductive System and Pregnancy
  • Intracerebral and Subarachnoid Hemorrhage Research

Peking University People's Hospital
2024-2025

Peking University
2024-2025

National Clinical Research Center for Digestive Diseases
2024

Jining Medical University
2014

Corticosteroids (CSs) are the initial therapy for immune thrombocytopenia (ITP); however, their efficacy is not adequately predicted. As a novel biomarker, composition of gut microbiota non-invasively tested and altered in patients with ITP. This study aims to develop predictive model that leverages microbiome data predict CS response ITP within four weeks treatment. Metagenomic sequencing performed on fecal samples from 212 ITP, 152 whom underwent treatment follow-up. Predictive models...

10.1002/advs.202410417 article EN cc-by Advanced Science 2025-03-05

Abstract Patients with steroid‐resistant or relapsed immune thrombocytopenia (ITP) suffer increased bleeding risk and impaired quality of life. Baricitinib, an oral Janus‐associated kinases (JAK) inhibitor, could alleviate both innate adaptive disorders without inducing in several autoimmune diseases. Accordingly, open‐label, single‐arm, phase 2 trial (NCT05446831) was initiated to explore the safety efficacy baricitinib ITP. Eligible patients were adults primary ITP who refractory...

10.1002/ajh.27433 article EN American Journal of Hematology 2024-07-09

To identify whether neuronavigation-assisted aspiration (NA) combined with electro-acupuncture (EA) provides better motor recovery in events of hypertensive putaminal hematoma (HPH) sized 30 to 50 ml. This study aims examine and have additional value cerebral hemorrhage rehabilitation.240 patients HPH ml admitted within 6 10 hours after stroke ictus were included this study. Group 1 contained 60 who underwent (NAEA), group 2 (NA), 3 (EA), 4 received conservative therapy consisting solely...

10.5137/1019-5149.jtn.16456-15.1 article EN Turkish Neurosurgery 2016-01-01

Summary The objective of this study was to identify independent prognostic factors viral encephalitis (VE) after allogeneic haematopoietic stem cell transplantation (allo‐HSCT) and establish a model post‐transplant VE patients with greater likelihood mortality. Among 5380 in our centre from 2014 2022, 211 who developed allo‐HSCT were reviewed retrospective study. Prognostic selected, constructed using Cox regression analysis. subsequently validated estimated the area under receiver operating...

10.1111/bjh.19683 article EN British Journal of Haematology 2024-08-04

Summary The global pandemic has resulted in the common occurrence of SARS‐CoV‐2 infection population. In post‐pandemic era, it is imperative to understand influence donor on outcomes after allogeneic haematopoietic stem cell transplantation (allo‐HSCT). We retrospectively analysed allo‐HSCTs from donors with mild or early recovery stage (ERS) (group 1, n = 65) and late 2, 120). Additionally, we included allo‐HSCT without prior as group 0 ( 194). Transplants different status had comparable...

10.1111/bjh.19594 article EN British Journal of Haematology 2024-06-24

Traumatic pericallosal aneurysms are not common complications of the closed and penetrating head injuries. We report 2 patients with traumatic aneurysm. This adds to our ability identify aneurysm in early period. The primary goals treatment identification intervention prevent bleeding. fragile, prone rupture, represent a challenging subset vascular lesions for either surgery or endovascular therapy. It is unclear whether surgical clipping coiling best option this type

10.1097/wnq.0000000000000078 article EN Neurosurgery Quarterly 2014-07-18

Objective To investigate the feasibility of preservation skull flap covered with periosteum in vivo and early cranioplasty patients decompressive craniectomy. Methods Sixty-seven underwent autologous using periosteum-covered preserved subcutaneously after craniectomy from January 2012 to December 2015 at Neurosurgery Department Rizhao People's Hospital. Their data were retrospectively reviewed. Cranioplasty was conducted within 4-8 weeks decompression for all patients. Part tissue...

10.3760/cma.j.issn.1001-2346.2017.07.012 article EN Zhonghua shenjing waike zazhi 2017-07-28
Coming Soon ...